AJP - Renal Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 280: F972-F979, 2001;
0363-6127/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (23)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ghosh, P. M.
Right arrow Articles by Kreisberg, J. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ghosh, P. M.
Right arrow Articles by Kreisberg, J. I.
Vol. 280, Issue 6, F972-F979, June 2001

Arginine vasopressin stimulates mesangial cell proliferation by activating the epidermal growth factor receptor

Paramita M. Ghosh1, Margarita Mikhailova2, Roble Bedolla1, and Jeffrey I. Kreisberg1,3

Departments of 1 Surgery and 2 Pathology, University of Texas Health Science Center at San Antonio, and 3 South Texas Veterans Health Care, San Antonio, Texas 78229

The potent vasoconstrictor arginine vasopressin (AVP) is also a mitogen for mesangial cells. Treatment with AVP decreased transit time through the cell cycle. AVP-stimulated mesangial cell growth by activating both the Ras mitogen-activated protein kinase (MAPK) and the phosphatidylinositol 3-kinase (PI3K) cell signaling pathways. Both the selective PI3K inhibitor LY-294002 and the MAPK kinase (MEK) inhibitor PD-98059 inhibited AVP-stimulated mesangial cell proliferation. However, LY-294002 was more potent, indicating an important role for PI3K activation in AVP-stimulated mesangial cell proliferation. AVP appeared to exert its effect on MAPK and PI3K activation, as well as on cell proliferation, by activating the epidermal growth factor receptor (EGF-R). Pretreatment with the tyrphostin-derived EGF-R antagonist AG-1478 inhibited mesangial cell proliferation as well as the activation of extracellular signal-regulated kinase 1/2 (ERK1/2 or p42/p44MAPK), and p70S6 kinase, a downstream effector of PI3K, providing evidence that MAPK and PI3K activation, respectively, occurred downstream of EGF-R activation. Treatment with rapamycin, an inhibitor of the p70S6 kinase activator mTOR, also resulted in growth inhibition, further suggesting the importance of the PI3K signaling pathway in AVP-induced proliferation. AVP treatment appeared to transactivate EGF-R by inducing tyrosine phosphorylation of the Ca2+/protein kinase C (PKC)-dependent nonreceptor tyrosine kinase, Pyk2, leading to Pyk2/c-Src association and c-Src activation. This was followed by association of c-Src with EGF-R and EGF-R activation. These data suggested that AVP-stimulated Pyk2 tyrosine phosphorylation to activate c-Src, thereby leading to EGF-R transactivation.

mitogen-activated protein kinase; phosphatidylinositol 3-kinase; p70S6 kinase; Pyk2; c-Src


This article has been cited by other articles:


Home page
 J Mol EndocrinolHome page
S. Volpi, Y. Liu, and G. Aguilera
Vasopressin increases GAGA binding activity to the V1b receptor promoter through transactivation of the MAP kinase pathway.
J. Mol. Endocrinol., June 1, 2006; 36(3): 581 - 590.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
J. C. Krepinsky, Y. Li, Y. Chang, L. Liu, F. Peng, D. Wu, D. Tang, J. Scholey, and A. J. Ingram
Akt Mediates Mechanical Strain-Induced Collagen Production by Mesangial Cells
J. Am. Soc. Nephrol., June 1, 2005; 16(6): 1661 - 1672.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
C.-K. Yeh, P. M. Ghosh, H. Dang, Q. Liu, A. L. Lin, B.-X. Zhang, and M. S. Katz
{beta}-Adrenergic-responsive activation of extracellular signal-regulated protein kinases in salivary cells: role of epidermal growth factor receptor and cAMP
Am J Physiol Cell Physiol, June 1, 2005; 288(6): C1357 - C1366.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
A. Perlman, L. M. Lawsin, P. Kolachana, M. Saji, J. Moore Jr., and M. D. Ringel
Angiotensin II Regulation of TGF-{beta} in Murine Mesangial Cells Involves Both PI3 Kinase and MAP Kinase
Ann. Clin. Lab. Sci., April 1, 2004; 34(3): 277 - 286.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
P. Robin, I. Boulven, C. Bole-Feysot, Z. Tanfin, and D. Leiber
Contribution of PKC-dependent and -independent processes in temporal ERK regulation by ET-1, PDGF, and EGF in rat myometrial cells
Am J Physiol Cell Physiol, April 1, 2004; 286(4): C798 - C806.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
B. M. Christensen, D. Marples, Y.-H. Kim, W. Wang, J. Frokiaer, and S. Nielsen
Changes in cellular composition of kidney collecting duct cells in rats with lithium-induced NDI
Am J Physiol Cell Physiol, April 1, 2004; 286(4): C952 - C964.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
H. Hua, S. Munk, and C. I. Whiteside
Endothelin-1 activates mesangial cell ERK1/2 via EGF-receptor transactivation and caveolin-1 interaction
Am J Physiol Renal Physiol, February 1, 2003; 284(2): F303 - F312.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
P. Robin, I. Boulven, C. Desmyter, S. Harbon, and D. Leiber
ET-1 stimulates ERK signaling pathway through sequential activation of PKC and Src in rat myometrial cells
Am J Physiol Cell Physiol, July 1, 2002; 283(1): C251 - C260.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online